Mostrelαn (Famotidine)

Famotidine, the active ingredient in Mostrelαn, is a H2 receptor antagonist presented as an oral dosage form for oral use. It reduces gastric acid secretion and is employed in the management of ulcer disease and gastro‑oesophageal reflux in adult patients and related acid‑related conditions. The drug is commonly prescribed worldwide and has a well‑established safety profile.

GNH USA supplies Mostrelαn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with reliable logistics and regulatory support.

Famotidine acts on acid‑related gastrointestinal conditions by inhibiting gastric acid secretion. - Peptic ulcer disease: promotes ulcer healing by lowering stomach acidity. - Gastro‑oesophageal reflux disease (GERD): relieves heartburn and esophageal irritation through acid reduction. - Erosive oesophagitis: facilitates mucosal recovery by decreasing acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Famotidine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild headache reported in some patients. - Dizziness: transient light‑headedness. - Constipation: reduced bowel movements. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic dysfunction: signs of liver injury such as jaundice. - Neutropenia: marked decrease in neutrophil count increasing infection risk.

When prescribing Famotidine, clinicians should consider several precautionary measures to ensure safe use. - Renal function assessment: adjust dose in patients with impaired renal clearance. - Elderly monitoring: observe for increased sensitivity to side effects. - Drug interaction review: evaluate concomitant medications that may affect acid suppression. - Discontinuation guidance: avoid abrupt cessation in patients with severe ulcer disease. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Famotidine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce famotidine absorption. - Ketoconazole: decreased antifungal effectiveness due to reduced gastric acidity. - Atazanavir: impaired antiviral absorption leading to subtherapeutic levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer coagulation monitoring. - Theophylline: possible elevation of plasma theophylline concentrations.